Processing 00000000.tx.1: Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant  Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant R. 

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "and"

Phrase: "variably penetrant  Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "and"

Phrase: "variably penetrant R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: Sherrington1, S. 

Phrase: "Sherrington1,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: Froelich2, S. 

Phrase: "Froelich2,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: Sorbi3, D. 

Phrase: "Sorbi3,"

Phrase: "D."
Processing 00000000.tx.5: Campion4, H. 

Phrase: "Campion4,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: Chi1, E. 

Phrase: "Chi1,"

Phrase: "E."
Processing 00000000.tx.7: A. 

Phrase: "A."
Processing 00000000.tx.8: Rogaeva1, G. 

Phrase: "Rogaeva1,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.9: Levesque1, E. 

Phrase: "Levesque1,"

Phrase: "E."
Processing 00000000.tx.10: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.11: Rogaev1, C. 

Phrase: "Rogaev1,"

Phrase: "C."
Processing 00000000.tx.12: Lin1, Y. 

Phrase: "Lin1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413217:LIN1 [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.13: Liang1, M. 

Phrase: "Liang1,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.14: Ikeda1, L. 

Phrase: "Ikeda1,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.15: Mar5, A. 

Phrase: "Mar5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538834:Mar5 [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.16: Brice6, Y. 

Phrase: "Brice6,"

Phrase: "Y."
Processing 00000000.tx.17: Agid6, M. 

Phrase: "Agid6,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.18: E. 

Phrase: "E."
Processing 00000000.tx.19: Percy7, F. 

Phrase: "Percy7,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.20: Clerget-Darpoux8, S. 

Phrase: "Clerget-Darpoux8,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.21: Piacentini3, G. 

Phrase: "Piacentini3,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.22: Marcon9, B. 

Phrase: "Marcon9,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.23: Nacmias3, L. 

Phrase: "Nacmias3,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.24: Amaducci3, T. 

Phrase: "Amaducci3,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.25: Frebourg4, L. 

Phrase: "Frebourg4,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.26: Lannfelt2, J. 

Phrase: "Lannfelt2,"

Phrase: "J."
Processing 00000000.tx.27: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.28: Rommens5 and P. 

Phrase: "Rommens5"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.29: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.30: St George-Hyslop1,* 1Centre for Research in Neurodegenerative Diseases, Department of Medicine, University of Toronto; 

Phrase: "St George-Hyslop1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "* 1Centre for Research"

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Toronto"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ";"
Processing 00000000.tx.31: Department of Medicine, Division of Neurology, The Toronto Hospital, Toronto, Ontario M5S 1A8, Canada, 2Karolinska Institute, Department of Clinical Neurosciences, Geriatric Medicine, Novum, KFC, 141 86 Huddinge, Sweden, 3Department of Neurology and Psychiatry, University of Florence, Viale Morgagni 65, Florence, Italy, 4Laboratoire de Genetique Moleculaire, CHU Rouen, 76031 Rouen, France, 5Department of Medical and Molecular Genetics, University of Toronto, and Research Institute, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, 6Department of Neurology, Hopital de la Salpetriere, and INSERM U289, 75013 Paris, France, 7Surrey Place Centre, Department of Obstetrics and Gynaecology and Dept. of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada and 8INSERM U155, Chateau de Longchamp, 75016, Paris, France and 9Department of Neurology, University of Udine, Udine, Italy Received February 20, 1996; 

Phrase: "Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Division of Neurology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   811   C0228059:division nervous system [Body System]
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "The Toronto Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Toronto,"

Phrase: "Ontario M5S 1A8,"

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "2Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Department of Clinical Neurosciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Geriatric Medicine,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0017469:Geriatric medicine [Biomedical Occupation or Discipline]
  1000   C1555747:Geriatric Medicine [Professional or Occupational Group]
  1000   C1555760:Geriatric Medicine [Professional or Occupational Group]
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]
   861   C1704440:Geriatric [Qualitative Concept]
   861   C1999167:geriatric [Population Group]

Phrase: "Novum,"

Phrase: "KFC,"

Phrase: "141 86 Huddinge,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "3Department of Neurology"

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "University of Florence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Viale Morgagni 65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450385:65 [Intellectual Product]

Phrase: "Florence,"

Phrase: "Italy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "4Laboratoire de Genetique Moleculaire,"

Phrase: "CHU Rouen,"

Phrase: "76031 Rouen,"

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "5Department of Medical"

Phrase: "and"

Phrase: "Molecular Genetics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035172:Research Institute [Organization]
   861   C0021622:institute [Organization]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1272753:Institute [Idea or Concept]

Phrase: "The Hospital for Sick Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0020017:Children's hospital [Health Care Related Organization]
   760   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   760   C1510665:Hospital [Qualitative Concept]

Phrase: "555 University Avenue,"

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "6Department of Neurology,"

Phrase: "Hopital de la Salpetriere,"

Phrase: "and"

Phrase: "INSERM U289,"

Phrase: "75013 Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030561:Paris [Geographic Area]
   861   C0331677:Paris [Plant]
   861   C1824032:PARIS [Gene or Genome]
   827 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "7Surrey Place Centre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "Department of Obstetrics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0028775:Obstetrics Department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Gynaecology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018417:Gynaecology [Biomedical Occupation or Discipline]
  1000   C0237419:Gynecology [Professional or Occupational Group]
   928 E C0205480:Gynaecologic [Spatial Concept]

Phrase: "and"

Phrase: "Dept."

Phrase: "of Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Ontario M5S 1A8,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "and"

Phrase: "8INSERM U155,"

Phrase: "Chateau de Longchamp,"

Phrase: "75016,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "9Department of Neurology,"

Phrase: "University of Udine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Udine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445353:Udine [Intellectual Product]

Phrase: "Italy Received February 20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022277:Italy [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1996"

Phrase: ";"
Processing 00000000.tx.32: Revised and Accepted April 17, 1996 Missense mutations in the presenilin 2 (PS-2) gene on chromosome 1 were sought by direct nucleotide sequence analysis of the open reading frame of 60 pedigrees with familial Alzheimer's disease (FAD). 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted April 17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1996 Missense mutations in the presenilin 2 (PS-2) gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0599155:Mutations, Missense [Genetic Function]
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "were"

Phrase: "sought by direct nucleotide sequence analysis of the open reading frame of 60 pedigrees"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   763   C0079941:Open Reading Frame [Gene or Genome]
   748   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   748   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   748   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0002778:Analysis [Laboratory Procedure]
   734   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0030761:pedigrees [Intellectual Product]
   734   C0034754:Reading [Daily or Recreational Activity]
   734   C0162326:Sequence [Nucleotide Sequence]
   734   C0162327:Sequence [Nucleotide Sequence]
   734   C0175566:Open [Spatial Concept]
   734   C0180979:Frame [Medical Device]
   734   C0439851:Direct [Qualitative Concept]
   734   C0936012:Analysis [Research Activity]
   734   C1519249:Sequence [Functional Concept]
   734   C1524024:analysis [Functional Concept]
   734   C1705179:Reading [Finding]
   734   C1705858:Frame [Manufactured Object]
   734   C1947931:Direct [Qualitative Concept]

Phrase: "with familial Alzheimer's disease (FAD)."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.33: In the majority of these pedigrees, PS-1 and [beta]-amyloid precursor protein ([beta]APP) gene mutations had been excluded. 

Phrase: "In the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of these pedigrees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:pedigrees [Intellectual Product]

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and ["

Phrase: "beta]-amyloid precursor protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "("

Phrase: "[beta]APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "gene mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0596611:gene mutations [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "been"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.34: While no additional PS-2 pathogenic mutations were detected, four silent nucleotide substitutions and alternative splicing of nucleotides 1338-1340 (Glu325) were observed. 

Phrase: "While"

Phrase: "no additional PS-2 pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "four silent nucleotide substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1555721:Substitution [Idea or Concept]
   779   C1706204:Substitution [Activity]

Phrase: "and"

Phrase: "alternative splicing of nucleotides 1338-1340"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002345:Alternative Splicing [Genetic Function]
   753   C0035687:Splicing [Genetic Function]
   753   C2610186:splicing [Genetic Function]

Phrase: "(Glu325"

Phrase: ")"

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.35: Analysis of additional members of a pedigree known to segregate a Met239Val mutation in PS-2 revealed that the age of onset of symptoms is highly variable (range 45-88 years). 

Phrase: "Analysis of additional members of a pedigree"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "segregate"

Phrase: "a Met239Val mutation in PS-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the age of onset of symptoms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   938   C3175531:Age of onset of symptoms [Clinical Attribute]
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "highly variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "(range 45-88 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.36: This variability is not attributable to differences in ApoE genotypes. 

Phrase: "This variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "is"

Phrase: "not attributable to differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596130:Attributable [Mental Process]

Phrase: "in ApoE genotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]
Processing 00000000.tx.37: These results suggest (i) that, in contrast to mutations in PS-1, mutations in PS-2 are a relatively rare cause of FAD; 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that,"

Phrase: "in contrast to mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PS-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "mutations in PS-2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "a relatively rare cause of FAD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1314792:disease cause [Functional Concept]
   744   C0015127:cause [Functional Concept]
   744   C1524003:Cause [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.38: (ii) that other genetic or environmental factors modify the AD phenotype associated with PS-2 mutations; 

Phrase: "(ii"

Phrase: ")"

Phrase: "that"

Phrase: "other genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "or"

Phrase: "environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the AD phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "associated with PS-2 mutations"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418986:PRESENILIN 2 [Gene or Genome]
   760   C0026882:Mutations [Genetic Function]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.39: and (iii) that still other FAD susceptibility genes remain to be identified. 

Phrase: "and ("

Phrase: "iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "that still"

Phrase: "other FAD susceptibility genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   823   C0919453:Susceptibility Gene [Gene or Genome]
   808   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.40: INTRODUCTION Missense mutations associated with early onsetAlzheimer's disease (AD) have been discovered in two related genes termed presenilin I on chromosome 14 (1 ) and presenilin II on chromosome 1 (2 ,3 ). 

Phrase: "INTRODUCTION Missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with early onsetAlzheimer's disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0243083:associated disease [Pathologic Function]
   797   C0679245:early disease [Temporal Concept]
   760   C0012634:Disease [Disease or Syndrome]
   760   C1279919:Early [Temporal Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "have"

Phrase: "been"

Phrase: "discovered in two related genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017337:Genes [Gene or Genome]
   760   C0205448:Two [Quantitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726   C1880355:Discover [Activity]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "presenilin I on chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "presenilin II on chromosome 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418986:PRESENILIN 2 [Gene or Genome]
   797   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1418985:PRESENILIN 1 [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(2 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.41: Analysis of a number of large data sets have revealed that missense mutations in the presenilin I (PS-1) gene are a frequent cause of early onset familial Alzheimer's disease (FAD), accounting for perhaps as much as 50% of all cases of early onset FAD (1 ,2 ,4 -6 ). 

Phrase: "Analysis of a number of large data sets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0010992:Data Analysis [Occupational Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that missense mutations in the presenilin I (PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C0599155:Mutations, Missense [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "a frequent cause of early onset familial Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1314792:disease cause [Functional Concept]
   742   C0015127:cause [Functional Concept]
   742   C1524003:Cause [Conceptual Entity]

Phrase: "(FAD"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "accounting for perhaps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0000938:Accounting [Occupational Activity]
   756 E C1551359:account [Idea or Concept]
   756 E C2741673:Account # [Clinical Attribute]
   756 E C2981730:Account [Classification]

Phrase: "as"

Phrase: "much as 50% of all cases of early onset FAD"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   816   C0338445:Familial Alzheimer's disease of early onset [Disease or Syndrome]
   783   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   770   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   766   C0814120:early disease onset [Disease or Syndrome]
   753   C0002395:Alzheimer's Disease [Disease or Syndrome]
   753   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C1833334:Early-onset [Finding]
   751   C0277558:Familial disease [Disease or Syndrome]
   751   C0277793:disease onset [Temporal Concept]
   751   C0679245:early disease [Temporal Concept]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0015576:familial [Family Group]
   736   C0241888:Familial [Functional Concept]
   736   C0332162:Onset [Qualitative Concept]
   736   C0868928:Cases [Functional Concept]
   736   C1279919:Early [Temporal Concept]
   736   C1533148:Cases [Quantitative Concept]
   715 E C0344339:disease family [Finding]
   703 E C1706255:CASE [Medical Device]
   703 E C1706256:Case [Conceptual Entity]

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4 -6"

Phrase: ")."
Processing 00000000.tx.42: In order to determine the frequency of mutations in the presenilin II (PS-2) gene, we undertook a survey for mutations in the open reading frame (ORF) of the PS-2 gene in 60 pedigrees with FAD. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "determine"

Phrase: "the frequency of mutations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C3178846:Mutation Frequency [Qualitative Concept]
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "in the presenilin II"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: "gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "we"

Phrase: "undertook"

Phrase: "a survey for mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038951:Survey [Intellectual Product]

Phrase: "in the open reading frame (ORF)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0079941:Open Reading Frame [Gene or Genome]
   901   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   827   C0034754:Reading [Daily or Recreational Activity]
   827   C0175566:Open [Spatial Concept]
   827   C0180979:Frame [Medical Device]
   827   C1705179:Reading [Finding]
   827   C1705858:Frame [Manufactured Object]
   755 E C0547049:Openness [Spatial Concept]

Phrase: "of the PS-2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "in 60 pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:pedigrees [Intellectual Product]

Phrase: "with FAD."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.43: The disease in these families was characterized by the occurrence of AD consistent with the NINDS-ADRDA criteria in at least three closely related subjects, often in more than one generation. 

Phrase: "The disease in these families"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   797   C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   756 E C0277558:Familial disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "characterized by the occurrence of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0243132:occurrence [Functional Concept]
   753   C1554210:occurrence [Idea or Concept]
   753   C1880022:Characterized [Activity]
   753   C2745955:Occurrence [Temporal Concept]

Phrase: "consistent with the NINDS-ADRDA criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in"

Phrase: "at least three closely related subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]

Phrase: "often in more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332183:Often [Temporal Concept]

Phrase: "than one generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.44: In these pedigrees, the age at onset (range: 35-82 years; 

Phrase: "In these pedigrees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:pedigrees [Intellectual Product]

Phrase: "the age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "(range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: ":"

Phrase: "35-82 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.45: 36 with mean age at onset <= 64 years; 

Phrase: "36 with mean age at onset"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0206132:Onset Age [Quantitative Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "<"

Phrase: "= 64 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.46: 14 with mean age at onset >= 65 years; 

Phrase: "14 with mean age at onset"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0206132:Onset Age [Quantitative Concept]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: ">"

Phrase: "= 65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.47: 10 with insufficient reliable data on age at onset) overlapped that observed in the pedigrees with known PS-2 mutations (onset between 45 and 72 years). 

Phrase: "10 with insufficient reliable data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205412:Insufficient [Qualitative Concept]
   760   C0231180:Insufficient [Qualitative Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "on age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: ")"

Phrase: "overlapped"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0185027:overlapped [Therapeutic or Preventive Procedure]
   966 E C1948020:Overlap [Conceptual Entity]

Phrase: "that"

Phrase: "observed in the pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030761:pedigrees [Intellectual Product]
   770   C1441672:Observed [Functional Concept]

Phrase: "with known PS-2 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(onset between 45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "72 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.48: To determine the penetrance of PS-2 mutations, we also examined several additional members of the FLO10 pedigree previously described with the Met239Val missense mutation in the PS-2 gene (2 ). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the penetrance of PS-2 mutations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0524899:Penetrance [Quantitative Concept]

Phrase: "we also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "several additional members of the FLO10 pedigree previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "described with the Met239Val missense mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0599155:Missense Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1552738:described [Idea or Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the PS-2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.49: Our data suggest that missense mutations in the PS-2 gene are a rare cause of AD and that these missense mutations may be subject to the modifying action of other genes or environmental influences. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that missense mutations in the PS-2 gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0599155:Mutations, Missense [Genetic Function]
   767   C0596611:gene mutations [Genetic Function]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "a rare cause of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "these missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "be subject to the modifying action of other genes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0017337:Genes [Gene or Genome]
   742   C0441472:Action [Functional Concept]
   742   C0681850:Subject [Group]
   742   C1550501:{Subject} [Idea or Concept]
   742   C1706203:Subject [Idea or Concept]
   742   C2349001:Subject [Human]
   742   C2697811:Subject [Functional Concept]
   742   C2987476:Be [Conceptual Entity]
   742   C3266814:Action [Activity]
   708   C0392747:MODIFY [Functional Concept]

Phrase: "or"

Phrase: "environmental influences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C0021399:influential [Idea or Concept]
Processing 00000000.tx.50: RESULTS Fibroblasts, transformed lymphoblasts or peripheral blood samples were obtained from at least one affected member of 60 kindreds with multiple (>3) family members affected by FAD that were ascertained through the familial Alzheimer's disease registry at the University of Toronto, through clinics at the University of Florence and the Massachusetts Alzheimer's Disease Research Centre, from the Karolinska Institute, Stockholm, Sweden, from French University Hospitals through the National INSERM network of France, and from the Indiana University Alzheimer's Disease DNA Bank and the NIA sponsored repository at the Coriell Institute. 

Phrase: "RESULTS Fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "transformed lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0229613:Lymphoblasts [Cell]
   861   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "or"

Phrase: "peripheral blood samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0229664:peripheral blood [Body Substance]

Phrase: "were"

Phrase: "obtained from"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "at least one affected member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0680022:member [Population Group]
   812   C2698041:Member [Professional or Occupational Group]

Phrase: "of 60 kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598429:kindreds [Qualitative Concept]

Phrase: "with multiple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439064:Multiple [Quantitative Concept]

Phrase: "("

Phrase: ">3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]

Phrase: "affected by FAD"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "were"

Phrase: "ascertained through the familial Alzheimer's disease registry"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C0920465:disease registry [Intellectual Product]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0034975:Registry [Intellectual Product]
   748   C0241888:Familial [Functional Concept]
   738 E C0344339:disease family [Finding]

Phrase: "at the University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "through clinics"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   966 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   916 E C0205210:Clinical [Qualitative Concept]

Phrase: "at the University of Florence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "the Massachusetts Alzheimer's Disease Research Centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "from the Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "from French University Hospitals"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:Hospitals, University [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1609061:Hospitals [Intellectual Product]
   793 E C1510665:Hospital [Qualitative Concept]

Phrase: "through the National INSERM network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "of France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and from the Indiana University Alzheimer's Disease DNA Bank"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0872147:DNA bank [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0021206:Indiana [Geographic Area]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0442598:Bank [Manufactured Object]
   742   C0872261:Bank [Manufactured Object]
   742   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "the NIA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1074110:Nia [Fungus]
  1000   C1955974:NIA [Health Care Related Organization]

Phrase: "sponsored"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711305:Sponsor [Human]
   966   C2347796:SPONSOR [Organization]

Phrase: "repository at the Coriell Institute."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0872261:Repository [Manufactured Object]
Processing 00000000.tx.51: Diagnosis of AD in affected members used the NINDS-ADRDA criteria or the similar CERAD criteria. 

Phrase: "Diagnosis of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011900:Diagnosis [Finding]
   790   C1704338:diagnosis [Qualitative Concept]
   790   C1704656:DIAGNOSIS [Research Activity]

Phrase: "in affected members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NINDS-ADRDA criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "or"

Phrase: "the similar CERAD criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.52: Mutations in the PS-1 and [beta]-amyloid precursor protein ([beta]APP) genes had previously been excluded in the majority of these pedigrees by sequencing of reverse transcriptase-polymerase chain reaction (RT-PCR) products corresponding to the PS-1 gene and genomic PCR products corresponding to exons 16 and 17 of [beta]APP. 

Phrase: "Mutations in the PS-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and ["

Phrase: "beta]-amyloid precursor protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "("

Phrase: "[beta]APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "excluded in the majority of these pedigrees"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0030761:pedigrees [Intellectual Product]
   748   C0680220:majority [Social Behavior]
   748   C1554077:Excluded [Idea or Concept]
   748   C2828389:Excluded [Activity]
   714 E C0332196:Exclude [Functional Concept]

Phrase: "by sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1553778:Sequencing [Intellectual Product]
  1000   C1561491:Sequencing [Functional Concept]

Phrase: "of reverse transcriptase-polymerase chain reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "(RT-PCR) products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: "corresponding to the PS-1 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017337:Gene [Gene or Genome]
   753   C1418867:Ps [Gene or Genome]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "genomic PCR products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "corresponding to exons 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "17 of [beta]APP."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   901   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   867   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   858   C1750295:beta protein [Genetic Function]
   858   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2825879:Amyloid, Beta [Laboratory Procedure]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0330390:Beta [Plant]
   799   C0439096:Beta [Intellectual Product]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]
   799   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.53: Analysis of the nucleotide sequence of RT-PCR products corresponding to the ORF of PS-2 in these 60 FAD pedigrees failed to uncover any additional mutations beyond the two initial mutations (Asn141Ile mutation in three related kindreds of Volga-German origin, and the Met239Val mutation in the FLO10 pedigree of Italian origin) previously reported in this data set (2 ). 

Phrase: "Analysis of the nucleotide sequence of RT-PCR products"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   762   C0200931:PCR analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "corresponding to the ORF of PS-2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0079941:Open Reading Frame [Gene or Genome]
   764   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   764   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418986:PRESENILIN 2 [Gene or Genome]
   742   C0034754:Reading [Daily or Recreational Activity]
   742   C0175566:Open [Spatial Concept]
   742   C0180979:Frame [Medical Device]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1705179:Reading [Finding]
   742   C1705858:Frame [Manufactured Object]

Phrase: "in these 60 FAD pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030761:pedigrees [Intellectual Product]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "uncover"

Phrase: "any additional mutations beyond the two initial mutations"

Phrase: "(Asn141Ile mutation in three related kindreds of Volga-German origin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0026882:Mutation [Genetic Function]
           Genetic mutation
   739   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the Met239Val mutation in the FLO10 pedigree of Italian origin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0026882:Mutation [Genetic Function]
           Genetic mutation
   739   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "previously"

Phrase: "reported in this data set"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0150098:Data Set [Intellectual Product]
   806   C1706233:Dataset [Intellectual Product]
   781   C0011000:data report [Research Activity]
   760   C0036849:Set [Mental Process]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1442518:Set [Functional Concept]
   760   C1511726:Data [Idea or Concept]
   760   C1705195:Set [Conceptual Entity]
   760   C3245479:data [Medical Device]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.54: Specific screening just for the Asn141Ile and Met239Val mutations in a supplemental set of genomic DNA samples from affected probands of 81 Swedish FAD pedigrees also failed to identify further instances of either mutation. 

Phrase: "Specific screening just for the Asn141Ile"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0220908:Screening [Health Care Activity]
   753   C0220909:screening [Functional Concept]
   753   C1698960:screening [Intellectual Product]
   753   C1710031:Screening [Diagnostic Procedure]
   753   C1710477:SCREENING [Research Activity]

Phrase: "and"

Phrase: "Met239Val mutations in a supplemental set of genomic DNA samples"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   741   C0026882:genomic mutation [Genetic Function]
           Mutations
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "from affected probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0702111:probands [Organism Attribute]
   827 E C1948021:Proband [Family Group]
   789 E C0702110:Propositus [Organism Attribute]

Phrase: "of 81 Swedish FAD pedigrees also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030761:pedigrees [Intellectual Product]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "further instances of either mutation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1550608:Instance [Idea or Concept]
Processing 00000000.tx.55: However, although no pathogenic nucleotide sequence differences were observed, four `silent' nucleotide substitutions were detected (T -> C at 626 bp/codon 23; C -> T at 806 bp/codon 147; C -> T at 1571 bp/codon 402; and G -> A at 1670 bp/codon 435-sequence numbering from Accession no. L44577). 

Phrase: "However,"

Phrase: "although"

Phrase: "no pathogenic nucleotide sequence differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1705241:*Difference [Quantitative Concept]
   779   C1705242:Difference [Qualitative Concept]
   729 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "four `silent' nucleotide substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1555721:Substitution [Idea or Concept]
   779   C1706204:Substitution [Activity]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(T -> C at 626 bp/codon 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2603360:T' [Clinical Attribute]

Phrase: "; C -> T at 806 bp/codon 147"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1553033:[c] [Quantitative Concept]

Phrase: "; C -> T at 1571 bp/codon 402"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1553033:[c] [Quantitative Concept]

Phrase: ";"

Phrase: "and"

Phrase: "G -> A at 1670 bp/codon 435-sequence numbering"

Phrase: "from Accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. L44577"

Phrase: ")."
Processing 00000000.tx.56: All of these substitutions occurred at the third nucleotide position of a codon, and would therefore be predicted not to cause a change in the amino acid sequence. 

Phrase: "All of these substitutions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C1555721:Substitution [Idea or Concept]
   737   C1706204:Substitution [Activity]

Phrase: "occurred at the third nucleotide position of a codon,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0009221:Codon [Nucleotide Sequence]
   742   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205437:Third [Quantitative Concept]
   742   C0733755:Position [Spatial Concept]
   742   C1095825:Codon [Plant]
   742   C1709305:Occurred [Activity]
   708 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "would"

Phrase: "therefore"

Phrase: "be"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a change in the amino acid sequence."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1953353:Amino acid change [Finding]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.57: A fifth sequence variant-the variable presence of nucleotides 1338-1340 encoding the Glu325 residuewas found in transcripts from most tissues. 

Phrase: "A fifth sequence variant-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "the variable presence of nucleotides 1338-1340"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the Glu325 residuewas"

Phrase: "found in transcripts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   756 E C0243095:Find [Finding]

Phrase: "from most tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.58: Transcripts with and without nucleotides 1338-1340, which reflects the use of an alternate splice donor sequence, were of approximately equal abundance in brain, fibroblasts and leukocytes. 

Phrase: "Transcripts with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and without nucleotides 1338-1340,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1515981:And [Idea or Concept]

Phrase: "which"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the use of an alternate splice donor sequence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]

Phrase: "were of approximately equal abundance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205163:Equal [Qualitative Concept]
   760   C0332232:Approximately [Qualitative Concept]
   760   C1549782:Equal [Idea or Concept]
   760   C2346714:Abundance [Qualitative Concept]

Phrase: "in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "and"

Phrase: "leukocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:Leukocytes [Cell]
Processing 00000000.tx.59: During the investigation of the PS-2 gene in several newly ascertained members of the FLO10 pedigree segregating the Met239Val mutation in PS-2, we identified an additional carrier of this mutation (subject III-20 in Table 1 ). 

Phrase: "During the investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "of the PS-2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "in several newly ascertained members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680022:members [Population Group]
   779 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the FLO10 pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:Pedigree [Intellectual Product]

Phrase: "segregating"

Phrase: "the Met239Val mutation in PS-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "an additional carrier of this mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C2985478:Mutation Carrier [Human]
   753   C0007294:Carrier [Finding]
   753   C0560175:Carrier [Finding]
   753   C1706209:Carrier [Medical Device]
   753   C3273162:Carrier [Intellectual Product]

Phrase: "(subject III-20 in Table 1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0039224:Table [Manufactured Object]
   753   C0439070:III [Intellectual Product]
   753   C0681850:Subject [Group]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1705160:III [Qualitative Concept]
   753   C1706073:Table [Medical Device]
   753   C1706074:Table [Intellectual Product]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]

Phrase: ")."
Processing 00000000.tx.60: Surprisingly, this subject was aged 87 years and had had no evidence for cognitive or memory impairment on serial follow-up over several years until age 84 years when she was noted to become mildly demented, and is now profoundly demented (Mini Mental Status Examination score 4/30) with clinical features that sustain a diagnosis of probable AD by the NINDS-ADRDA criteria. 

Phrase: "Surprisingly,"

Phrase: "this subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "was"

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "87 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "had"

Phrase: "had"

Phrase: "no evidence for cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "or"

Phrase: "memory impairment on serial follow-up over several years"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0233794:Memory impairment [Mental or Behavioral Dysfunction]
   764   C1963167:Memory impairment [Finding]
   742   C0684336:Impairment [Pathologic Function]

Phrase: "until age 84 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1510829:Age-Years [Temporal Concept]
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "when"

Phrase: "she"

Phrase: "was"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "become"

Phrase: "mildly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750532:MILDLY [Idea or Concept]
  1000   C2945599:Mildly [Qualitative Concept]

Phrase: "demented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0860630:demented [Mental or Behavioral Dysfunction]

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "now profoundly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948052:Now [Temporal Concept]

Phrase: "demented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0860630:demented [Mental or Behavioral Dysfunction]

Phrase: "(Mini Mental Status Examination score 4/30"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C0278060:Mental status [Finding]
   818   C0420607:status examination [Finding]
   795   C0229992:mental [Mental Process]
   795   C0445542:Mini [Organism Attribute]
   795   C0449438:Status [Qualitative Concept]
   795   C0449820:Score [Quantitative Concept]
   712 E C0229993:Psychic [Functional Concept]

Phrase: ")"

Phrase: "with clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "that"

Phrase: "sustain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443318:sustain [Functional Concept]
  1000   C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "a diagnosis of probable AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0332148:Probable diagnosis [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "by the NINDS-ADRDA criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.61: A review of clinical data on additional members of the extended pedigree also uncovered two other subjects in the direct lineage of the family who had either historical evidence for late onset AD (subject I-2, the affected grandfather of III-20 who died at 75 years with dementia) or who currently have clinical features consistent with probable AD using the NINDS-ADRDA criteria (subject III-39 onset at 88 years). 

Phrase: "A review of clinical data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0282443:Review [Intellectual Product]
   760   C1552617:Review [Idea or Concept]

Phrase: "on additional members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the extended pedigree also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:Pedigree [Intellectual Product]

Phrase: "uncovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439845:Uncovered [Functional Concept]

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other subjects in the direct lineage of the family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "had"

Phrase: "either historical evidence for late onset AD (subject I-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0332120:Evidence [Functional Concept]

Phrase: "the affected grandfather of III-20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0337475:Grandfather [Family Group]

Phrase: "who"

Phrase: "died at 75 years"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0011065:Died [Organism Function]
   770   C0439234:years [Temporal Concept]
   770   C1546956:Died [Finding]
   737 E C0439508:/year [Temporal Concept]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "or"

Phrase: "who currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "have"

Phrase: "clinical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "consistent with probable AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NINDS-ADRDA criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "(subject III-39 onset at 88 years"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332162:Onset [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.62: We and others have previously reported that the genotype at the Apolipoprotein E gene can modulate the age of onset of Alzheimer's disease in subjects with the Val717Ile mutation in [beta]APP (7 ,8 ). 

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the genotype at the Apolipoprotein E gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017431:Genotype [Organism Attribute]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the age of onset of Alzheimer's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   748   C0001779:Age [Organism Attribute]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with the Val717Ile mutation in [beta]APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   877   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   852   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   845   C1750295:beta protein [Genetic Function]
   845   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C2825879:Amyloid, Beta [Laboratory Procedure]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0330390:Beta [Plant]
   795   C0439096:Beta [Intellectual Product]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]
   795   C2004068:Beta [Qualitative Concept]

Phrase: "(7 ,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.63: However, in the FLO10 family with the Met239Val mutation in PS-2, ApoE genotypes do not correlate with age of onset (Table 1 ). 

Phrase: "However,"

Phrase: "in the FLO10 family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "with the Met239Val mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PS-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "ApoE genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with age of onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: Thus, the very elderly symptomatic subject III-20 (onset 84 years) has the same ApoE genotype ([epsilon]3/[epsilon]3) as three other affected carriers of the Met239Val mutation, all of whom developed symptoms at a younger age (onset 45-72 years). 

Phrase: "Thus,"

Phrase: "the very elderly symptomatic subject III-20"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C0001792:Elderly [Population Group]
   799   C0231220:Symptomatic [Functional Concept]
   799   C0439070:III [Intellectual Product]
   799   C0442824:Very [Qualitative Concept]
   799   C0681850:Subject [Group]
   799   C1550501:{Subject} [Idea or Concept]
   799   C1705160:III [Qualitative Concept]
   799   C1706203:Subject [Idea or Concept]
   799   C1999167:elderly [Population Group]
   799   C2349001:Subject [Human]
   799   C2697811:Subject [Functional Concept]

Phrase: "(onset 84 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "has"

Phrase: "the same ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017431:Genotype [Organism Attribute]

Phrase: "("

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "as three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "other affected carriers of the Met239Val mutation,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C2985478:Mutation Carrier [Human]
   748   C0007294:carriers [Finding]
   714 E C0560175:Carrier [Finding]
   714 E C1706209:Carrier [Medical Device]
   714 E C3273162:Carrier [Intellectual Product]

Phrase: "all of whom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "developed"

Phrase: "symptoms at a younger age (onset 45-72 years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0683368:symptoms [Functional Concept]
   742   C1457887:Symptoms [Sign or Symptom]

Phrase: ")."
Processing 00000000.tx.65: Moreover, the affected carrier IV-21, with the ApoE genotype of [epsilon]3/[epsilon]4 developed symptoms at an age (48 years) similar to that of his affected sibling IV-18 with an ApoE genotype of [epsilon]3/[epsilon]3 (onset = 45 years) (Table 1 , Fig. 1 ). 

Phrase: "Moreover,"

Phrase: "the affected carrier IV-21,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0007294:Carrier [Finding]
   812   C0392760:Affected [Functional Concept]
   812   C0560175:Carrier [Finding]
   812   C1314939:Affected [Functional Concept]
   812   C1706209:Carrier [Medical Device]
   812   C3273162:Carrier [Intellectual Product]

Phrase: "with the ApoE genotype of [epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 developed symptoms at an age (48 years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0683368:symptoms [Functional Concept]
   744   C1457887:Symptoms [Sign or Symptom]

Phrase: ")"

Phrase: "similar to that of his affected sibling IV-18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "with an ApoE genotype of [epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "(onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "= 45 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "(Table 1 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.66: Our sample size is too small to draw reliable conclusions about the presence or absence of interactions between the ApoE genotype and the Asn141Ile mutation (Table 1 ). 

Phrase: "Our sample size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242618:Sample Size [Quantitative Concept]
   861   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "too small to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0700321:Small [Quantitative Concept]

Phrase: "draw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013113:Draw [Intellectual Product]

Phrase: "reliable conclusions about the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707478:Conclusions [Idea or Concept]

Phrase: "or"

Phrase: "absence of interactions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "between the ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "the Asn141Ile mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: Figure 1.

Phrase: "Figure 1."
Processing 00000000.tx.68: Abbreviated pedigree diagram of FLO10. 

Phrase: "Abbreviated pedigree diagram of FLO10."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681494:Diagram [Intellectual Product]
Processing 00000000.tx.69: Small type face roman numerals are the pedigree locations of each subject. 

Phrase: "Small type face roman numerals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0439067:Roman numeral [Intellectual Product]
   771   C1720186:Numeral [Intellectual Product]

Phrase: "are"

Phrase: "the pedigree locations of each subject."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0450429:locations [Spatial Concept]
   719 E C1515974:Location [Body Location or Region]
Processing 00000000.tx.70: Solid symbols = AD-affected subjects; 

Phrase: "Solid symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "= AD-affected subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: ";"
Processing 00000000.tx.71: hatched symbols = at-risk subjects; 

Phrase: "hatched symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "= at-risk subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
   734   C1444641:At risk [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.72: open symbols = not at-risk. 

Phrase: "open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "="

Phrase: "not at-risk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.73: Where known, age at onset (or age at death) is denoted by arabic numerals. 

Phrase: "Where known, age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0206132:age onset [Quantitative Concept]
   804   C0001779:Age [Organism Attribute]
   804   C0332162:Onset [Qualitative Concept]

Phrase: "("

Phrase: "or"

Phrase: "age at death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1543138:Age at death [Clinical Attribute]
  1000   C1546180:Age at death [Clinical Attribute]
   858   C0742983:age death [Finding]
   790   C0001779:Age [Organism Attribute]

Phrase: ")"

Phrase: "is"

Phrase: "denoted by arabic numerals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0439071:Arabic numeral [Intellectual Product]
   770   C1552588:Arabic [Intellectual Product]
   737   C1720186:Numeral [Intellectual Product]
Processing 00000000.tx.74: ApoE genotypes are depicted. 

Phrase: "ApoE genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "are"

Phrase: "depicted."
Processing 00000000.tx.75: With the exception of subject III-39, whose genotypes at PS-2 and ApoE are unknown because no biological samples are available, all affected subjects carried the PS-2 Met239Val mutation. 

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of subject III-39,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0439070:III [Intellectual Product]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1705160:III [Qualitative Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "whose genotypes at PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "are"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "because"

Phrase: "no biological samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C2347026:Biological Sample [Conceptual Entity]
           Sample
   827   C0370003:Sample [Substance]

Phrase: "are"

Phrase: "available,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "all affected subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the PS-2 Met239Val mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.76: DISCUSSION Although the large cadre of FAD pedigrees reported here does not represent an unbiased survey, the paucity of missense mutations in the PS-2 gene amongst FAD pedigrees in our data set suggests that, in contrast to mutations in the ORF of PS-1, mutations in the ORF of this gene are a rare cause of FAD, at least in Caucasian populations. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "Although"

Phrase: "the large cadre of FAD pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0683625:cadre [Population Group]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an unbiased survey,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038951:Survey [Intellectual Product]

Phrase: "the paucity of missense mutations"

Phrase: "in the PS-2 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "amongst FAD pedigrees"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030761:pedigrees [Intellectual Product]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "in our data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0150098:Data Set [Intellectual Product]
  1000   C1706233:Dataset [Intellectual Product]
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1511726:Data [Idea or Concept]
   861   C1705195:Set [Conceptual Entity]
   861   C3245479:data [Medical Device]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "in contrast to mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the ORF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0079941:Open Reading Frame [Gene or Genome]
   901   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   827   C0034754:Reading [Daily or Recreational Activity]
   827   C0175566:Open [Spatial Concept]
   827   C0180979:Frame [Medical Device]
   827   C1705179:Reading [Finding]
   827   C1705858:Frame [Manufactured Object]
   755 E C0547049:Openness [Spatial Concept]

Phrase: "of PS-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "mutations in the ORF of this gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0596611:gene mutations [Genetic Function]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "a rare cause of FAD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1314792:disease cause [Functional Concept]
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in Caucasian populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.77: We can confidently exclude mutations in intronic sequences associated with RNA splice sites [indeed only one such mutation which affects splicing of exon 10 of PS-1 has been found in FAD affected subjects (T. Miki et al., in preparation)]. 

Phrase: "We"

Phrase: "can"

Phrase: "confidently"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "mutations in intronic sequences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1881250:Intronic Mutation [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with RNA splice sites"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   862   C0887916:RNA Splice Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205145:Sites [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C2825164:Site [Spatial Concept]

Phrase: "[indeed only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "such mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "splicing of exon 10 of PS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]

Phrase: "has"

Phrase: "been"

Phrase: "found in FAD affected subjects"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   814   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   774   C0277558:Familial disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0150312:Found [Quantitative Concept]
   748   C0241888:Familial [Functional Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   738 E C0344339:disease family [Finding]
   714 E C0243095:Find [Finding]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "(T. Miki et al.,"

Phrase: "in preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.78: However, until the 5' UTR and 3' UTR sequences have been searched for pathogenic mutations, we cannot exclude the formal possibility that mutations might exist in these sequences in some of our pedigrees. 

Phrase: "However,"

Phrase: "until"

Phrase: "the 5' UTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "and"

Phrase: "3' UTR sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C0600600:3' UTR [Biologically Active Substance,Nucleotide Sequence]

Phrase: "have"

Phrase: "been"

Phrase: "searched for pathogenic mutations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   770   C0450254:Pathogenic [Organism]
   770   C1706202:Searched [Activity]
   737 E C1552603:search [Intellectual Product]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the formal possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "that mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "might"

Phrase: "exist in these sequences"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C2987476:Exist [Conceptual Entity]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "in some"

Phrase: "of our pedigrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:pedigrees [Intellectual Product]
Processing 00000000.tx.79: Nevertheless, there are two corollaries to the conclusion that PS-2 ORF mutations are rare. 

Phrase: "Nevertheless,"

Phrase: "there"

Phrase: "are"

Phrase: "two corollaries to the conclusion"

Phrase: "that PS-2 ORF mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "rare."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]
Processing 00000000.tx.80: First, unless a phenotype uniquely associated with or at least enriched in subjects with PS-2 mutants can be found, screening programs for mutations in the ORF of PS-2 are likely to have a low yield. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "unless"

Phrase: "a phenotype uniquely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "associated with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332281:Associated with [Qualitative Concept]
           Associated
   799 E C0750490:Associate [Idea or Concept]
   799 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or at least"

Phrase: "enriched in subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0359583:enriched [Food]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with PS-2 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "screening"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0220908:Screening [Health Care Activity]
  1000   C0220909:screening [Functional Concept]
  1000   C1698960:screening [Intellectual Product]
  1000   C1710031:Screening [Diagnostic Procedure]
  1000   C1710477:SCREENING [Research Activity]
   966 E C1305399:screen [Functional Concept]
   966 E C1705053:Screen [Medical Device]

Phrase: "programs for mutations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0376691:Programs [Intellectual Product]
   790   C3484370:Programs [Functional Concept]
   756 E C1709697:Program [Conceptual Entity]
   756 E C2728259:Program [Pharmacologic Substance]

Phrase: "in the ORF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0079941:Open Reading Frame [Gene or Genome]
   901   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   827   C0034754:Reading [Daily or Recreational Activity]
   827   C0175566:Open [Spatial Concept]
   827   C0180979:Frame [Medical Device]
   827   C1705179:Reading [Finding]
   827   C1705858:Frame [Manufactured Object]
   755 E C0547049:Openness [Spatial Concept]

Phrase: "of PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "a low yield."
Processing 00000000.tx.81: Second, and more importantly, other as yet unidentified FAD susceptibility loci must exist. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "more importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "other as yet unidentified FAD susceptibility loci"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   784   C0477364:Other Alzheimer's disease [Mental or Behavioral Dysfunction]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0012655:Disease susceptibility [Clinical Attribute]
           Susceptibility
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0277558:Familial disease [Disease or Syndrome]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0205394:Other [Qualitative Concept]
   742   C0205427:Unidentified [Qualitative Concept]
   742   C0220898:Susceptibility [Organism Attribute]
   742   C0241888:Familial [Functional Concept]
   742   C1264642:Susceptibility [Functional Concept]
   742   C1547045:*Susceptibility [Quantitative Concept]
   726 E C0344339:disease family [Finding]
   708   C1708726:Locus [Gene or Genome]

Phrase: "must"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.82: Table 1 Age of onset relative to the genotypes at the ApoE and PS-2 genes Subject PS-2 mutation Clinical status Age at onset or (current age) ApoE genotype AG09907 Asn141Ile Affected ?71 years [epsilon]3/[epsilon]3 AG09369 Asn141Ile Affected 56 years [epsilon]4/[epsilon]4 AG09905 Asn141Ile Affected ?72 years [epsilon]3/[epsilon]4 Flo10-IV36 Met239Val Unaffected (42 years) [epsilon]3/[epsilon]3 Flo10-III35 Met239Val Affected 68 years [epsilon]3/[epsilon]3 Flo10-III20 Met239Val Mildly affected 84 years [epsilon]3/[epsilon]3 Flo10-III21 Met239Val Affected 72 years [epsilon]3/[epsilon]3 Flo10-IV18 Met239Val Affected 45 years [epsilon]3/[epsilon]3 Flo10-IV21 Met239Val Affected 48 years [epsilon]3/[epsilon]4 The age of symptom onset or current age of PS-2 mutation carriers are displayed along with each subject's ApoE genotype. 

Phrase: "Table 1 Age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "relative to the genotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "at the ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "PS-2 genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Genes [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "Subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "PS-2 mutation Clinical status Age at onset or (current age) ApoE genotype AG09907 Asn141Ile"

Phrase: "Affected ?71 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 AG09369 Asn141Ile"

Phrase: "Affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "56 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4/"

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 AG09905 Asn141Ile"

Phrase: "Affected ?72 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 Flo10-IV36 Met239Val"

Phrase: "Unaffected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986417:Unaffected [Conceptual Entity]

Phrase: "(42 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 Flo10-III35 Met239Val"

Phrase: "Affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "68 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 Flo10-III20 Met239Val Mildly"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "84 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 Flo10-III21 Met239Val"

Phrase: "Affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "72 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 Flo10-IV18 Met239Val"

Phrase: "Affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "45 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 Flo10-IV21 Met239Val"

Phrase: "Affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "48 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4"

Phrase: "The age of symptom onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "or"

Phrase: "current age of PS-2 mutation carriers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C2598519:Current age [Temporal Concept]
   748   C0001779:Age [Organism Attribute]

Phrase: "are"

Phrase: "displayed along with each subject's ApoE genotype."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017431:Genotype [Organism Attribute]
   748   C0523511:APOE [Laboratory Procedure]
   748   C0681850:Subject [Group]
   748   C0870432:displayed [Functional Concept]
   748   C1412481:APOE [Gene or Genome]
   748   C1550501:{Subject} [Idea or Concept]
   748   C1706203:Subject [Idea or Concept]
   748   C2349001:Subject [Human]
   748   C2697811:Subject [Functional Concept]
   714 E C1705417:Display [Manufactured Object]
Processing 00000000.tx.83: The other conclusion to be drawn from our data is that the age of symptom onset in subjects with PS-2 mutations is generally older (45-88 years) than that observed for most PS-1 mutations (25-65 years), and is highly variable even amongst affected members of the same pedigree. 

Phrase: "The"

Phrase: "other conclusion to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusion [Idea or Concept]

Phrase: "be"

Phrase: "drawn from our data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C0013113:Draw [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the age of symptom onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with PS-2 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "is"

Phrase: "generally older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0580836:Old [Temporal Concept]

Phrase: "(45-88 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "than that"

Phrase: "observed for most PS-1 mutations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026882:Mutations [Genetic Function]
   753   C1418867:Ps [Gene or Genome]
   753   C1441672:Observed [Functional Concept]
   753   C1518860:PS [Geographic Area]
   753   C1552158:Ps [Body Part, Organ, or Organ Component]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(25-65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "highly variable even amongst affected members of the same pedigree."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   739   C0030761:Pedigree [Intellectual Product]
   739   C0205250:Highly [Qualitative Concept]
   739   C0392760:Affected [Functional Concept]
   739   C0439828:Variable [Qualitative Concept]
   739   C0445247:Same [Qualitative Concept]
   739   C0680022:members [Population Group]
   739   C1314939:Affected [Functional Concept]
   706 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.84: This contrasts sharply with the experience with PS-1 mutations, where the age of onset is generally quite similar amongst affected members of the same family, and often amongst members of different families with the same mutation (1 ,2 ,4 -6 ). 

Phrase: "This contrasts sharply with the experience"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1979874:Contrast [Qualitative Concept]

Phrase: "with PS-1 mutations,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "where"

Phrase: "the age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "generally quite similar amongst affected members of the same family,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "often amongst members of different families"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   783   C0086282:Family Members [Family Group]
   767 E C1611821:Family Member [Intellectual Product]
   753   C0015576:Families [Family Group]
   753   C0332183:Often [Temporal Concept]
   753   C0680022:members [Population Group]
   753   C1704727:Family [Conceptual Entity]
   753   C1705242:Different [Qualitative Concept]
   719 E C2698041:Member [Professional or Occupational Group]

Phrase: "with the same mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4 -6"

Phrase: ")."
Processing 00000000.tx.85: Because to date all subjects with AD in the FLO10 pedigree have inherited the Met239Val mutation, it is unlikely that the late onset cases represent phenocopies and/or that it represents a polymorphism in linkage disequilibrium with a nearby pathogenic mutation. 

Phrase: "Because to date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011008:Date [Temporal Concept]
   790   C2348077:Date [Food]

Phrase: "all"

Phrase: "subjects with AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "in the FLO10 pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030761:Pedigree [Intellectual Product]

Phrase: "have"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "the Met239Val mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the late onset cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "phenocopies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678921:Phenocopy [Organism Attribute]

Phrase: "and/or"

Phrase: "that"

Phrase: "it"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a polymorphism in linkage disequilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "with a nearby pathogenic mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.86: Consequently, the most parsimonious explanation is that there is a single cause of the disease (the Met239Val mutation) and that the phenotype is modified by other genetic or environmental factors. 

Phrase: "Consequently,"

Phrase: "the most parsimonious explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that there"

Phrase: "is"

Phrase: "a single cause of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1314792:disease cause [Functional Concept]
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "("

Phrase: "the Met239Val mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "modified by other genetic"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   833   C0205349:Modified By [Qualitative Concept]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0392747:Modified [Functional Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "or"

Phrase: "environmental factors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.87: The limited number of subjects with the Asn141Ile mutation in our data set prevents rigorous conclusions about any interactions between the ApoE genotype and this mutation. 

Phrase: "The limited number of subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "with the Asn141Ile mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in our data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0150098:Data Set [Intellectual Product]
  1000   C1706233:Dataset [Intellectual Product]
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1511726:Data [Idea or Concept]
   861   C1705195:Set [Conceptual Entity]
   861   C3245479:data [Medical Device]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "rigorous conclusions about any interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707478:Conclusions [Idea or Concept]

Phrase: "between the ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "this mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.88: However, analysis of a larger data set by T. 

Phrase: "However,"

Phrase: "analysis of a larger data set"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1704642:Analysis Dataset [Conceptual Entity]
   783   C0010992:Data Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "by T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.89: Bird and G. 

Phrase: "Bird"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.90: Schellenberg also reveals no obvious interaction between the genotypes at ApoE and PS-2 Asn141Ile (manuscript in preparation). 

Phrase: "Schellenberg also"

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "no obvious interaction between the genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "at ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "and"

Phrase: "PS-2 Asn141Ile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(manuscript in preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: ")."
Processing 00000000.tx.91: This absence of a close correlation between the ApoE genotype and age of symptom onset in subjects with PS-2 mutation has two implications. 

Phrase: "This absence of a close correlation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "between the ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "age of symptom onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   770   C0001779:Age [Organism Attribute]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with PS-2 mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "has"

Phrase: "two implications."
Processing 00000000.tx.92: First, in view of parallel observations showing no apparent interaction between ApoE genotype and mutations in PS-1 (7 ,9 ,10 ), together with the structural and amino acid sequence similarities of the PS-1 and PS-2 proteins (1 -3 ), it is likely that the functional effect of PS-1 and PS-2 mutations are similar and are either remote from the functional effect of the ApoE [epsilon]4 allele, or affect a biochemical pathway leading to AD which is different from that influenced by ApoE [epsilon]4. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "in view of parallel observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no apparent interaction between ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "mutations in PS-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(7 ,"

Phrase: "9 ,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "together with the structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "amino acid sequence similarities of the PS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C1710052:Sequence Similarity [Quantitative Concept]
   711   C2348205:Similarity [Qualitative Concept]

Phrase: "and"

Phrase: "PS-2 proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(1 -3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the functional effect of PS-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "PS-2 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "are"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "either remote from the functional effect of the ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205157:Remote [Spatial Concept]
   742   C0443203:Remote [Spatial Concept]
   742   C1550013:remote [Idea or Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 allele,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "or"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "a biochemical pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1704259:Biochemical Pathway [Molecular Function]
           Pathway
   861   C0205474:Biochemical [Functional Concept]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to AD"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "different from that"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "influenced by ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4."
Processing 00000000.tx.93: Second, the variation in age of onset in PS-2 mutation carriers argues that other modifying environmental or genetic factors (e.g. other polymorphisms within the presenilin genes or differences in other genes) must exist. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the variation in age of onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "in PS-2 mutation carriers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   844   C2985478:Mutation Carrier [Human]
   812   C0007294:carriers [Finding]
   779 E C0560175:Carrier [Finding]
   779 E C1706209:Carrier [Medical Device]
   779 E C3273162:Carrier [Intellectual Product]

Phrase: "argues"

Phrase: "that"

Phrase: "other modifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392747:MODIFY [Functional Concept]

Phrase: "environmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environmental [Spatial Concept]

Phrase: "or"

Phrase: "genetic factors"
Meta Candidates (Total=18; Excluded=14; Pruned=0; Remaining=4)
   861   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   861   C0314603:Genetic [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   805 E C0005615:Birth [Organism Function]
   805 E C0035150:Reproduction [Organism Function]
   805 E C0079946:origin [Classification]
   805 E C0439659:Origin [Temporal Concept]
   805 E C1550512:origin [Intellectual Product]
   805 E C1550722:birth [Idea or Concept]
   805 E C3245487:birth [Intellectual Product]
   777 E C0454729:Natal [Geographic Area]
   777 E C0559522:Genital [Body System]
   777 E C1546649:Genital [Intellectual Product]
   777 E C1550642:Genital [Body Substance]
   768 E C0205313:Original [Idea or Concept]
   768 E C2347409:Original [Occupational Activity]
   750 E C0598240:originality [Mental Process]

Phrase: "("

Phrase: "e.g."

Phrase: "other polymorphisms within the presenilin genes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0678951:gene polymorphisms [Genetic Function]
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "or"

Phrase: "differences in other genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: ")"

Phrase: "must"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.94: The nature of these other factors remains to be determined. 

Phrase: "The nature of these"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349590:Nature [Idea or Concept]
   770   C1262865:Nature [Functional Concept]

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.95: However, if these modifying factors can be identified, they might be exploitable as a therapeutic tool. 

Phrase: "However,"

Phrase: "if"

Phrase: "these modifying factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "can"

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "they"

Phrase: "might"

Phrase: "be"

Phrase: "exploitable as a therapeutic tool."
Processing 00000000.tx.96: MATERIALS AND METHODS Subjects with familially clustered Alzheimer's disease (as defined by the occurrence of at least three first or second degree relatives with AD) were recruited from patients referred for the investigation of dementia at the University of Toronto, University of Florence, the Massachusetts Alzheimer's Disease Research Centre, the Huddinge Hospital of the Karolinska Institute, and French University Hospitals. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Subjects with familially clustered Alzheimer's disease"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0012641:disease cluster [Quantitative Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0681850:Subject [Group]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]
   719   C1555715:Cluster [Idea or Concept]
   719   C1704332:Cluster [Quantitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "defined by the occurrence of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C2745955:Occurrence [Temporal Concept]
   760   C3539106:Defined [Intellectual Product]

Phrase: "at least three first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205435:First [Quantitative Concept]
   827   C1279901:First [Qualitative Concept]

Phrase: "or"

Phrase: "second degree relatives with AD)"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   845   C1519210:Second Degree Relative [Family Group]
   760   C0080103:Relatives [Family Group]
   726 E C0205345:Relative [Qualitative Concept]
   726 E C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "recruited from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030705:Patients [Patient or Disabled Group]

Phrase: "referred for the investigation of dementia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0205543:referred [Functional Concept]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]
   753   C1691010:Referred [Functional Concept]

Phrase: "at the University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "University of Florence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "the Massachusetts Alzheimer's Disease Research Centre,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "the Huddinge Hospital of the Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   748   C1510665:Hospital [Qualitative Concept]

Phrase: "and"

Phrase: "French University Hospitals."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:Hospitals, University [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospitals [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1609061:Hospitals [Intellectual Product]
   793 E C1510665:Hospital [Qualitative Concept]
Processing 00000000.tx.97: All subjects provided informed consent using institutionally approved protocols. 

Phrase: "All"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "institutionally approved protocols."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C2346846:Approved Protocol [Functional Concept]
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.98: The diagnosis of AD was made in affected pedigree members by direct clinical examination and standard laboratory procedures which met or exceeded the stringency of the NINCDS-ADRDA criteria (11 ,12 ). 

Phrase: "The diagnosis of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "made in affected pedigree members"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0030761:Pedigree [Intellectual Product]
   760   C0392760:Affected [Functional Concept]
   760   C0680022:members [Population Group]
   760   C1314939:Affected [Functional Concept]
   726   C1881534:Make [Functional Concept]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "by direct clinical examination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031809:Clinical examination [Health Care Activity]
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "standard laboratory procedures"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   901   C0022885:Laboratory Procedures [Laboratory Procedure]
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   827   C3244292:laboratory [Functional Concept]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: "which"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "or"

Phrase: "exceeded"

Phrase: "the stringency of the NINCDS-ADRDA criteria"

Phrase: "(11 ,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.99: Evidence of AD in deceased family members was ascertained through the investigation of medical and family records as previously described (13 ). 

Phrase: "Evidence of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in deceased family members"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   983   C0425043:Deceased Family Member [Finding]
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "was"

Phrase: "ascertained through the investigation of medical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205476:Medical [Functional Concept]
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]

Phrase: "and"

Phrase: "family records"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034869:Records [Intellectual Product]
   861   C1548330:Records [Idea or Concept]
   861   C1553414:Records [Qualitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.100: Additional FAD pedigree samples were obtained from the Cornell Institute (Camden, NJ) (N = 4) and from the Indiana University Alzheimer's Disease DNA Bank (Indianapolis, IN) (N = 6). 

Phrase: "Additional FAD pedigree samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0370003:Sample [Substance]
   766   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from the Cornell Institute"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(Camden,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "(N = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and from the Indiana University Alzheimer's Disease DNA Bank"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0872147:DNA bank [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0021206:Indiana [Geographic Area]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0442598:Bank [Manufactured Object]
   742   C0872261:Bank [Manufactured Object]
   742   C1515981:And [Idea or Concept]

Phrase: "(Indianapolis,"

Phrase: "IN) (N = 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.101: Mutations were sought in the ORF of the PS-1 gene (47/60 pedigrees) and in exon 16 and 17 of the [beta]APP gene (51/60 pedigrees) using the methods previously described (1 ,14 ,15 ). 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "sought in the ORF of the PS-1 gene"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   775   C0079941:Open Reading Frame [Gene or Genome]
   756   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   756   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0017337:Gene [Gene or Genome]
   738   C0034754:Reading [Daily or Recreational Activity]
   738   C0175566:Open [Spatial Concept]
   738   C0180979:Frame [Medical Device]
   738   C1418867:Ps [Gene or Genome]
   738   C1518860:PS [Geographic Area]
   738   C1552158:Ps [Body Part, Organ, or Organ Component]
   738   C1705179:Reading [Finding]
   738   C1705858:Frame [Manufactured Object]

Phrase: "(47/60 pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:pedigrees [Intellectual Product]

Phrase: ")"

Phrase: "and in exon 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "17 of the [beta]APP gene"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   833   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   815 E C3538722:Amyloid Beta Precursor Protein [Laboratory Procedure]
           Amyloid Precursor Protein
           Amyloid Precursor Beta
   793   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2825879:Amyloid, Beta [Laboratory Procedure]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1750295:beta protein [Genetic Function]
   767   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   767 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C2004068:Beta [Qualitative Concept]

Phrase: "(51/60 pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030761:pedigrees [Intellectual Product]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methods previously"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "14 ,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.102: The PS-2 gene ORF was investigated in the North American and Italian pedigrees by isolating complimentary DNA fragments by amplification using RT-PCR and the oligonucleotide primer sequences and reaction conditions as previously described (2 ). 

Phrase: "The PS-2 gene ORF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   861   C0079941:Open Reading Frame [Gene or Genome]
   827   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   799   C0034754:Reading [Daily or Recreational Activity]
   799   C0175566:Open [Spatial Concept]
   799   C0180979:Frame [Medical Device]
   799   C1705179:Reading [Finding]
   799   C1705858:Frame [Manufactured Object]
   727 E C0547049:Openness [Spatial Concept]

Phrase: "was"

Phrase: "investigated in the North American"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0425358:NORTH AMERICAN [Finding]
   806   C2700615:North American [Population Group]
   760   C0596070:American [Population Group]
   760   C1292732:investigated [Functional Concept]
   760   C1709269:North [Spatial Concept]

Phrase: "and"

Phrase: "Italian pedigrees by isolating complimentary DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030761:pedigrees [Intellectual Product]

Phrase: "fragments by amplification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332255:fragment [Functional Concept]
   790   C0486805:Fragments [Body Substance]
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]
   790   C1708096:Fragment [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "the oligonucleotide primer sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
   734   C0206415:Oligonucleotide Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "reaction conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.103: In the French families, RT-PCR was performed using primers F1: 5'-caggaaacagctatgaccgagctgaccctcaaatacgg and F2: 5'-tgtaaaacgacggccagtgagatcatacacagagatgg to recover codons 85-257, and primers F3: 5'-caggaaacagctatgacctcaagtacctcccagagtgg and F4: 5'-tgtaaaacgacggccagtagcctgtggcacaccatgtc to recover codons 251-448. 

Phrase: "In the French families,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers F1"

Phrase: ":"

Phrase: "5'-caggaaacagctatgaccgagctgaccctcaaatacgg"

Phrase: "and"

Phrase: "F2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439453:F2 [Quantitative Concept]
  1000   C1414504:F2 [Gene or Genome]

Phrase: ":"

Phrase: "5'-tgtaaaacgacggccagtgagatcatacacagagatgg to"

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: "codons 85-257,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "and"

Phrase: "primers F3"

Phrase: ":"

Phrase: "5'-caggaaacagctatgacctcaagtacctcccagagtgg"

Phrase: "and"

Phrase: "F4"

Phrase: ":"

Phrase: "5'-tgtaaaacgacggccagtagcctgtggcacaccatgtc to"

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: "codons 251-448."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]
Processing 00000000.tx.104: The nucleotide sequence of the RT-PCR products for each affected pedigree member was determined using fluorescent dye terminator or dye primer cycle sequencing. 

Phrase: "The nucleotide sequence of the RT-PCR products"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "for each affected pedigree member"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0680022:member [Population Group]
   827   C2698041:Member [Professional or Occupational Group]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescent dye terminator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0851166:TERMINATOR [Pharmacologic Substance]
   827   C1705818:Terminator [Manufactured Object]
   827   C3205287:Terminator [Pharmacologic Substance]
   734   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "dye primer cycle sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1553778:Sequencing [Intellectual Product]
   812   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.105: Mutations were detected by analysis of the resultant chromatograms for heterozygous nucleotidesubstitutions using both direct inspection and the Factura (ver 1.2.0) and the Sequence Navigator (ver 1.0.1b15) software packages ABI, Foster City, CA. 

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected by analysis of the resultant chromatograms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0442726:Detected [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1524024:analysis [Functional Concept]

Phrase: "for heterozygous nucleotidesubstitutions"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both direct inspection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0199219:Inspection [Functional Concept]

Phrase: "and"

Phrase: "the Factura"

Phrase: "(ver 1.2.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0302357:ver [Diagnostic Procedure]
   812   C0546834:VER [Diagnostic Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "the Sequence Navigator"

Phrase: "(ver 1.0.1b15"

Phrase: ")"

Phrase: "software packages ABI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1328319:ABI [Clinical Attribute]

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA."
Processing 00000000.tx.106: The presence of the T -> C substitution at base pair 1624 of the PS-2 cDNA sequence which gives rise to the Met239Val mutation was assessed in genomic DNA as previously described (2 ). 

Phrase: "The presence of the T -> C substitution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at base pair 1624"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0600436:Base Pair [Molecular Function]
   827   C0002055:base [Inorganic Chemical]
   827   C0178499:Base [Chemical Viewed Functionally]
   827   C1709450:Pair [Qualitative Concept]
   827   C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]
   743 E C0016617:Foundation [Organization]
   743 E C1626935:Bases [Quantitative Concept]

Phrase: "of the PS-2 cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "which"

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to the Met239Val mutation"

Phrase: "was"

Phrase: "assessed in genomic DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0017428:Genomic [Gene or Genome]
   770   C0887950:genomic [Biomedical Occupation or Discipline]
   770   C1516048:Assessed [Activity]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.107: Genotypes at ApoE were determined by PCR amplification and HhaI digestion as previously described (16 ,17 ). 

Phrase: "Genotypes at ApoE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "determined by PCR amplification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "HhaI digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0012238:Digestion [Organism Function]
   861   C2349986:Digestion [Research Activity]
   805 E C0443277:Peptic [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(16 ,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.108: ACKNOWLEDGEMENTS This work was supported by the Alzheimer Association of Ontario, Canadian Genetic Diseases Network, Medical Research Council of Canada, American Health Assistance Foundation, National Institute of Health, the Scottish Rite Charitable Foundation, the Eva Gordon Memorial Trust, Lifebeat, the Swedish Medical Research Council (project 10819)(LL), INSERM (network 492002), Consiglio Nazionale delle Richerche (PF Aging 952631) (SS), Telethon Italy (E.304) (BN), Glaxo Canada (RS), Helen B. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by the Alzheimer Association of Ontario,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0004083:Association [Mental Process]
   748   C0029040:Ontario [Geographic Area]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1521721:Supported [Conceptual Entity]
   714 E C0183683:Support [Medical Device]

Phrase: "Canadian Genetic Diseases Network,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1513822:Network [Professional or Occupational Group]
   812   C1705739:Network [Manufactured Object]
   812   C1882071:Network [Conceptual Entity]

Phrase: "Medical Research Council of Canada,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0079816:Medical Research [Research Activity]
   806   C1556038:Medical Research [Professional or Occupational Group]
   760   C0035168:research [Research Activity]
   760   C0205476:Medical [Functional Concept]
   760   C0242481:Research [Research Activity]
   760   C1551807:Council [Population Group]

Phrase: "American Health Assistance Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "National Institute of Health,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C0027468:health national institute [Health Care Related Organization]
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "the Scottish Rite Charitable Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "the Eva Gordon Memorial Trust,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0237935:Trust [Individual Behavior]
   812   C3245466:trust [Idea or Concept]

Phrase: "Lifebeat,"

Phrase: "the Swedish Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0079816:Medical Research [Research Activity]
   861   C1556038:Medical Research [Professional or Occupational Group]
   812   C0035168:research [Research Activity]
   812   C0205476:Medical [Functional Concept]
   812   C0242481:Research [Research Activity]
   812   C1551807:Council [Population Group]

Phrase: "(project 10819"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709701:Project [Conceptual Entity]

Phrase: ")"

Phrase: "(LL"

Phrase: ")"

Phrase: ","

Phrase: "INSERM"

Phrase: "(network 492002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1513822:Network [Professional or Occupational Group]
   861   C1705739:Network [Manufactured Object]
   861   C1882071:Network [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "Consiglio Nazionale delle Richerche"

Phrase: "(PF"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "952631"

Phrase: ")"

Phrase: "(SS),"

Phrase: "Telethon Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022277:Italy [Geographic Area]

Phrase: "(E.304"

Phrase: ")"

Phrase: "(BN"

Phrase: ")"

Phrase: ","

Phrase: "Glaxo Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006823:Canada [Geographic Area]

Phrase: "(RS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539879:RS [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Helen B."
Processing 00000000.tx.109: Hunter Foundation (GL and HC), Peterborough-Burgess Fellowship (EAR), Ontario Mental Health Foundation (MEP). 

Phrase: "Hunter Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "(GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: "and"

Phrase: "HC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
  1000   C1413512:Hc [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "Peterborough-Burgess Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015770:Fellowship [Educational Activity]

Phrase: "(EAR"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0013443:Ear [Body Part, Organ, or Organ Component]
  1000   C0521421:Ear [Body Part, Organ, or Organ Component]
   944 E C0521422:Otic [Spatial Concept]
   944 E C1272926:Otic [Biomedical or Dental Material]
   944 E C1418197:OTOR [Gene or Genome]
   944 E C1522191:Otic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "Ontario Mental Health Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "(MEP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707163:MEP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.110: PStGH and JMR are Scholars of the Medical Research Council of Canada. 

Phrase: "PStGH"

Phrase: "and"

Phrase: "JMR"

Phrase: "are"

Phrase: "Scholars of the Medical Research Council of Canada."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684017:scholars [Professional or Occupational Group]
Processing 00000000.tx.111: Cell lines were obtained from the Indiana University Alzheimer's Disease DNA bank (P30 AG10133). 

Phrase: "Cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from the Indiana University Alzheimer's Disease DNA bank"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0872147:DNA bank [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0021206:Indiana [Geographic Area]
   742   C0041740:University [Manufactured Object,Organization]
   742   C0442598:Bank [Manufactured Object]
   742   C0872261:Bank [Manufactured Object]
   742   C1301820:Obtained [Functional Concept]
   715   C0277564:Acquired disease [Disease or Syndrome]
   708 E C1706701:Obtain [Activity]

Phrase: "(P30 AG10133"

Phrase: ")."
Processing 00000000.tx.112: REFERENCES 1 Sherrington, R., Rogaev, E., Liang, Y. et al. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.,"

Phrase: "Liang,"

Phrase: "Y. et al."
Processing 00000000.tx.113: (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning of a gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0009015:Cloning [Research Activity]

Phrase: "in early onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.114: Nature, 375, 754-760. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754-760."
Processing 00000000.tx.115: MEDLINE Abstract 2 Rogaev, E.I., Sherrington, R., Rogaeva, E.A. et al. 

Phrase: "MEDLINE Abstract 2 Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.A. et al."
Processing 00000000.tx.116: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's Disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a novel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's Disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.117: Nature, 376, 775-778. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775-778."
Processing 00000000.tx.118: MEDLINE Abstract 3 Levy-Lahad, E. et al. 

Phrase: "MEDLINE Abstract 3 Levy-Lahad,"

Phrase: "E. et al."
Processing 00000000.tx.119: (1995) A familial Alzheimer's Disease locus on chromosome 1. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A familial Alzheimer's Disease locus on chromosome 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.120: Science, 269, 970-973. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "970-973."
Processing 00000000.tx.121: MEDLINE Abstract 4 Cruts, M., Martin, J.-J., and Van Broeckhoven, C. 

Phrase: "MEDLINE Abstract 4 Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Martin,"

Phrase: "J.-J.,"

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.122: (1995) Molecular genetic analysis of familial early-onset Alzheimer's Disease linked to chromosome 14q24.3. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Molecular genetic analysis of familial early-onset Alzheimer's Disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   764   C0679560:genetic analysis [Laboratory Procedure]
   764   C0796344:Genetic Analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "linked to chromosome 14q24.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1520594:14q24.3 [Cell Component]
   797   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C1520591:14q24 [Cell Component]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.123: Hum. 

Phrase: "Hum."
Processing 00000000.tx.124: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.125: Genet., 4, 2363-2371. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "2363-2371."
Processing 00000000.tx.126: MEDLINE Abstract 5 Campion, D., Flaman, J.-M., Brice, A. et al. 

Phrase: "MEDLINE Abstract 5 Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Flaman,"

Phrase: "J.-"

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A. et al."
Processing 00000000.tx.127: (1995) Mutations of the Presenilin-1 gene in families with early onsetAlzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mutations of the Presenilin-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early onsetAlzheimer's disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0679245:early disease [Temporal Concept]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.128: Hum. 

Phrase: "Hum."
Processing 00000000.tx.129: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.130: Genet., 4, 2373-2377. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "2373-2377."
Processing 00000000.tx.131: MEDLINE Abstract 6 The Alzheimer's Disease Collaborative Group (1995) The structure of the presenilin I gene and the identification of six mutations in early onset AD pedigrees. 

Phrase: "MEDLINE Abstract 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]

Phrase: "The Alzheimer's Disease Collaborative Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(1995"

Phrase: ")"

Phrase: "The structure of the presenilin I gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C1517495:Gene Structure [Gene or Genome]
   748   C0678594:Structure [Spatial Concept]
   738 E C0017366:Structural gene [Gene or Genome]

Phrase: "and"

Phrase: "the identification of six mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in early onset AD pedigrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030761:pedigrees [Intellectual Product]
Processing 00000000.tx.132: Nature Genet., 11, 219-222. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "219-222."
Processing 00000000.tx.133: 7 St George-Hyslop, P.H., Tsuda, T., Crapper McLachlan, D., Karlinsky, H., Pollen, D. and Lippa, C. 

Phrase: "7 St George-Hyslop,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Crapper McLachlan,"

Phrase: "D."

Phrase: ","

Phrase: "Karlinsky,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: "and"

Phrase: "Lippa,"

Phrase: "C."
Processing 00000000.tx.134: (1994) Alzheimer's Disease and possible gene interaction. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "possible gene interaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0596610:gene interaction [Genetic Function]
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.135: Science, 263, 536-537. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "263,"

Phrase: "536-537."
Processing 00000000.tx.136: 8 Nacmias, B., Latteraga, S., Tulen, P., Piacentini, S., Bracco, L., Amaducci, L. and Sorbi, S. 

Phrase: "8 Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Latteraga,"

Phrase: "S."

Phrase: ","

Phrase: "Tulen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Piacentini,"

Phrase: "S."

Phrase: ","

Phrase: "Bracco,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Amaducci,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sorbi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.137: (1995) ApoE genotype and familial Alzheimer's Disease: a possible influence on age-of-onset in APP717Val -> Ile mutated families. 

Phrase: "(1995"

Phrase: ")"

Phrase: "ApoE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "familial Alzheimer's Disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "a possible influence on age-of-onset"

Phrase: "in APP717Val -"

Phrase: "> Ile mutated families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.138: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.139: Lett., 183, 1-3. 

Phrase: "Lett.,"

Phrase: "183,"

Phrase: "1-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.140: MEDLINE Abstract 9 van Broeckhoven, C., Backhovens, H., Cruts, M., Martin, J.J., Crook, R., Houlden, H., and Hardy, J. 

Phrase: "MEDLINE Abstract 9 van Broeckhoven,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Martin,"

Phrase: "J.J.,"

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.141: (1994) APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's Disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with chromosome 14 encoded Alzheimer's Disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   862   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.142: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.143: Lett., 169, 179-180. 

Phrase: "Lett.,"

Phrase: "169,"

Phrase: "179-180."
Processing 00000000.tx.144: MEDLINE Abstract 10 The French Alzheimer's Disease Collaborative Study Group (1996) Apolipoprotein E genotype does not affect age at onset in patients with chromosome 14 encoded Alzheimer's Disease. 

Phrase: "MEDLINE Abstract 10"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]

Phrase: "The French Alzheimer's Disease Collaborative Study Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0441833:Group [Idea or Concept]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]

Phrase: "(1996"

Phrase: ")"

Phrase: "Apolipoprotein E genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotype [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "age at onset in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0206132:Onset Age [Quantitative Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]

Phrase: "with chromosome 14 encoded Alzheimer's Disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   862   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.145: J. 

Phrase: "J."
Processing 00000000.tx.146: Med. 

Phrase: "Med."
Processing 00000000.tx.147: Genet., in press. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "in press."
Processing 00000000.tx.148: 11 McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. 

Phrase: "11 McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.149: (1984) Clinical diagnosis of Alzheimer Disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on Alzheimer Disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer Disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of the Department of Health and Human Services Task force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.150: Neurology, 34, 939-944. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.151: MEDLINE Abstract 12 Khachaturian, Z.S. 

Phrase: "MEDLINE Abstract 12 Khachaturian,"

Phrase: "Z.S."
Processing 00000000.tx.152: (1985) Diagnosis of Alzheimer Disease. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Diagnosis of Alzheimer Disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.153: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.154: Neurol., 42, 1097-1105. 

Phrase: "Neurol.,"

Phrase: "42,"

Phrase: "1097-1105."
Processing 00000000.tx.155: MEDLINE Abstract 13 St George-Hyslop, P., Haines, J., Rogaev, E. et al. 

Phrase: "MEDLINE Abstract 13 St George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J.,"

Phrase: "Rogaev,"

Phrase: "E. et al."
Processing 00000000.tx.156: (1992) Genetic evidence for a novel Familial Alzheimer Disease gene on chromosome 14. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Genetic evidence for a novel Familial Alzheimer Disease gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 14."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008656:Chromosome 14 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.157: Nature Genet., 2, 330-334. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "330-334."
Processing 00000000.tx.158: MEDLINE Abstract 14 Karlinsky, H., Vaula, G., Haines, J.L. et al. 

Phrase: "MEDLINE Abstract 14 Karlinsky,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Vaula,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Haines,"

Phrase: "J.L. et al."
Processing 00000000.tx.159: (1992) Molecular and prospective phenotypic characterization of a pedigree with Familial Alzheimer Disease and a missense mutation in codon 717 of the [beta]-amyloid precursor protein (APP) gene. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "prospective phenotypic characterization of a pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "with Familial Alzheimer Disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "a missense mutation in codon 717"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599155:Missense Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of the [beta]-amyloid precursor protein (APP) gene."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   771   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   722   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1750295:beta protein [Genetic Function]
   708   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.160: Neurology, 42, 1445-1453. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "42,"

Phrase: "1445-1453."
Processing 00000000.tx.161: MEDLINE Abstract 15 Mullan, M.J., Crawford, F., Axelman, K. et al. 

Phrase: "MEDLINE Abstract 15 Mullan,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Axelman,"

Phrase: "K. et al."
Processing 00000000.tx.162: (1992) A pathogenic mutation for probable Alzheimer's Disease in the APP gene at the N-terminus of [beta]-amyloid. 

Phrase: "(1992"

Phrase: ")"

Phrase: "A pathogenic mutation for probable Alzheimer's Disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the APP gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "at the N-terminus of [beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "]-amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.163: Nature Genet., 1. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.164: 345-347. 

Phrase: "345-347."
Processing 00000000.tx.165: 16 Saunders, A., Strittmatter, W.J., Schmechel, S. et al. 

Phrase: "16 Saunders,"

Phrase: "A.,"

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "S. et al."
Processing 00000000.tx.166: (1993) Association of Apoliprotein E allele [epsilon]4 with the late-onset familial and sporadic Alzheimer Disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Association of Apoliprotein E allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 with the late-onset familial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015576:familial [Family Group]
   753   C0205087:Late [Temporal Concept]
   753   C0241888:Familial [Functional Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "sporadic Alzheimer Disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.167: Neurology, 43, 1467-1472. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "43,"

Phrase: "1467-1472."
Processing 00000000.tx.168: MEDLINE Abstract 17 Tsuda, T., Lopez, R., Rogaeva, E., Freedman, M., Haines, J., Crapper McLachlan, D., Duara, R., and St George-Hyslop, P. 

Phrase: "MEDLINE Abstract 17 Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lopez,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Freedman,"

Phrase: "M."

Phrase: ","

Phrase: "Haines,"

Phrase: "J.,"

Phrase: "Crapper McLachlan,"

Phrase: "D."

Phrase: ","

Phrase: "Duara,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.169: (1994) Are the associations between Alzheimer Disease and the apolipoprotein genes on chr 19 due to linkage disequilibrium? 

Phrase: "(1994"

Phrase: ")"

Phrase: "Are"

Phrase: "the associations between Alzheimer Disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Associations [Mental Process]
   726 E C0439849:Association [Qualitative Concept]
   726 E C0596306:Association [Phenomenon or Process]
   726 E C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the apolipoprotein genes on chr 19"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1445865:Apolipoprotein gene [Gene or Genome]
   767   C1413398:CHR gene [Gene or Genome]
   753   C0017337:Genes [Gene or Genome]

Phrase: "due to linkage disequilibrium?"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]
Processing 00000000.tx.170: Ann. 

Phrase: "Ann."
Processing 00000000.tx.171: Neurol., 36, 97-100. 

Phrase: "Neurol.,"

Phrase: "36,"

Phrase: "97-100."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
Processing 00000000.tx.172: MEDLINE Abstract *To whom correspondence should be addressed This page is maintained by OUP admin. 

Phrase: "MEDLINE Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0000857:Abstract [Occupational Activity]
   861   C0600678:Abstract [Intellectual Product]
   861   C1552863:Abstract [Idea or Concept]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "maintained by OUP admin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
Processing 00000000.tx.173: Last updated Thu Oct 31 15:25:15 GMT 1996. 

Phrase: "Last updated Thu Oct 31 15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0039677:THU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   799   C0039958:THU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0450355:31 [Intellectual Product]
   799   C1517741:Last [Qualitative Concept]
   766   C1519814:Update [Temporal Concept]

Phrase: ":"

Phrase: "25"

Phrase: ":"

Phrase: "15 GMT 1996."
Processing 00000000.tx.174: Part of the OUP Journals World Wide Web service.

Phrase: "Part of the OUP Journals World Wide Web service."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.175: Copyright Oxford University Press, 1996

Phrase: "Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "1996"

